These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38134256)

  • 21. Modifiable Risk Factors for Stroke and Strategies for Stroke Prevention.
    Hill VA; Towfighi A
    Semin Neurol; 2017 Jun; 37(3):237-258. PubMed ID: 28759906
    [No Abstract]   [Full Text] [Related]  

  • 22. Personalising secondary prevention: different treatments for different strokes.
    Markus H
    Pract Neurol; 2020 Feb; 20(1):34-38. PubMed ID: 31484793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fixed-dose combination treatment after stroke for secondary prevention in China: a national community-based study.
    Longde W; Ling Y; Yang H; Yi Z; Yongjun W; Xunming J; Xiaoyuan N; Qiumin Q; Li H; Yuming X; Mei L; Jiayi S; Jing L; Dong Z
    Stroke; 2015 May; 46(5):1295-300. PubMed ID: 25782466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibrates in the secondary prevention of cardiovascular disease (infarction and stroke). Results of a systematic review and meta-analysis of the Cochrane collaboration.
    Millan J; Pintó X; Brea A; Blasco M; Hernández-Mijares A; Ascaso J; Diaz A; Mantilla T; Pedro-Botet J
    Clin Investig Arterioscler; 2018; 30(1):30-35. PubMed ID: 29395493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disparities between prescribing of secondary prevention therapies for stroke and coronary artery disease in general practice.
    Heeley E; Anderson C; Patel A; Cass A; Peiris D; Weekes A; Chalmers J
    Int J Stroke; 2012 Dec; 7(8):649-54. PubMed ID: 21978147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormone therapy for preventing cardiovascular disease in post-menopausal women.
    Boardman HM; Hartley L; Eisinga A; Main C; Roqué i Figuls M; Bonfill Cosp X; Gabriel Sanchez R; Knight B
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD002229. PubMed ID: 25754617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aspirin for Primary and Secondary Prevention of Cardiovascular Disease.
    Godley RW; Hernandez-Vila E
    Tex Heart Inst J; 2016 Aug; 43(4):318-9. PubMed ID: 27547141
    [No Abstract]   [Full Text] [Related]  

  • 28. Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association.
    Lackland DT; Elkind MS; D'Agostino R; Dhamoon MS; Goff DC; Higashida RT; McClure LA; Mitchell PH; Sacco RL; Sila CA; Smith SC; Tanne D; Tirschwell DL; Touzé E; Wechsler LR; ; ; ; ; ;
    Stroke; 2012 Jul; 43(7):1998-2027. PubMed ID: 22627990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Secondary prophylaxis of stroke from a neurological perspective].
    Seidel G
    Herz; 2013 May; 38(3):251-60. PubMed ID: 23471343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiplatelets in stroke prevention.
    Pinto A; Di Raimondo D; Tuttolomondo A; Buttà C; Licata G
    Curr Vasc Pharmacol; 2013 Nov; 11(6):803-11. PubMed ID: 24484461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Primary and secondary prevention of stroke].
    Masuhr F; Busch MA
    Internist (Berl); 2012 Dec; 53(12):1496-504. PubMed ID: 23111592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Socioeconomic factors and use of secondary preventive therapies for cardiovascular diseases in South Asia: The PURE study.
    Gupta R; Islam S; Mony P; Kutty VR; Mohan V; Kumar R; Thakur JS; Shankar VK; Mohan D; Vijayakumar K; Rahman O; Yusuf R; Iqbal R; Shahid M; Mohan I; Rangarajan S; Teo KK; Yusuf S
    Eur J Prev Cardiol; 2015 Oct; 22(10):1261-71. PubMed ID: 24942224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention and Management of Stroke in Obstetrics and Gynecology.
    Barghouthi T; Bushnell C
    Clin Obstet Gynecol; 2018 Jun; 61(2):235-242. PubMed ID: 29543620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey.
    Yusuf S; Islam S; Chow CK; Rangarajan S; Dagenais G; Diaz R; Gupta R; Kelishadi R; Iqbal R; Avezum A; Kruger A; Kutty R; Lanas F; Lisheng L; Wei L; Lopez-Jaramillo P; Oguz A; Rahman O; Swidan H; Yusoff K; Zatonski W; Rosengren A; Teo KK;
    Lancet; 2011 Oct; 378(9798):1231-43. PubMed ID: 21872920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Acute treatment and secondary prophylaxis of ischemic stroke : An excellent example for personalized medicine].
    Wachter R; Gröschel K
    Internist (Berl); 2018 Mar; 59(3):241-251. PubMed ID: 29459990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular care of patients with stroke and high risk of stroke: The need for interdisciplinary action: A consensus report from the European Society of Cardiology Cardiovascular Round Table.
    Doehner W; Mazighi M; Hofmann BM; Lautsch D; Hindricks G; Bohula EA; Byrne RA; Camm AJ; Casadei B; Caso V; Cognard C; Diener HC; Endres M; Goldstein P; Halliday A; Hopewell JC; Jovanovic DR; Kobayashi A; Kostrubiec M; Krajina A; Landmesser U; Markus HS; Ntaios G; Pezzella FR; Ribo M; Rosano GM; Rubiera M; Sharma M; Touyz RM; Widimsky P
    Eur J Prev Cardiol; 2020 May; 27(7):682-692. PubMed ID: 31569966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antihypertensive treatment of patients with cardiovascular disease but without hypertension.
    LaRiccia PJ; Morgan S
    JAMA; 2011 Jun; 305(21):2170-1; author reply 2171. PubMed ID: 21632478
    [No Abstract]   [Full Text] [Related]  

  • 38. Secondary prevention of atherothrombotic or cryptogenic stroke.
    Tai WA; Albers GW
    Circulation; 2014 Jan; 129(4):527-31. PubMed ID: 24470474
    [No Abstract]   [Full Text] [Related]  

  • 39. TIMI risk score for secondary prevention of recurrent cardiovascular events in a real-world cohort of post-non-ST-elevation myocardial infarction patients.
    Huang D; Cheng YY; Wong YT; Yung SY; Chan KW; Lam CC; Hai J; Lau CP; Wong KL; Feng YQ; Tan N; Chen JY; Wu MX; Su X; Yan H; Song D; Tse HF; Chan PH; Siu CW; Tam CC
    Postgrad Med J; 2019 Jul; 95(1125):372-377. PubMed ID: 31123174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended-release acetylsalicylic acid for secondary prevention of stroke and cardiovascular events.
    Bliden KP; Tantry US; Chaudhary R; Byun S; Gurbel PA
    Expert Rev Cardiovasc Ther; 2016 Jul; 14(7):779-91. PubMed ID: 27215735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.